113 related articles for article (PubMed ID: 29158900)
1. Single measurement of plasminogen activator inhibitor-1 in sepsis: is it useful for evaluating the severity or prognosis of sepsis?
Koyama K; Nunomiya S
J Intensive Care; 2017; 5():63. PubMed ID: 29158900
[No Abstract] [Full Text] [Related]
2. Plasminogen Activator Inhibitor 1 for Predicting Sepsis Severity and Mortality Outcomes: A Systematic Review and Meta-Analysis.
Tipoe TL; Wu WKK; Chung L; Gong M; Dong M; Liu T; Roever L; Ho J; Wong MCS; Chan MTV; Tse G; Wu JCY; Wong SH
Front Immunol; 2018; 9():1218. PubMed ID: 29967603
[TBL] [Abstract][Full Text] [Related]
3. Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory Study.
Nusshag C; Rupp C; Schmitt F; Krautkrämer E; Speer C; Kälble F; Tamulyte S; Bruckner T; Zeier M; Reiser J; Weigand MA; Uhle F; Merle U; Morath C; Brenner T
Crit Care Med; 2019 Dec; 47(12):e999-e1007. PubMed ID: 31584458
[TBL] [Abstract][Full Text] [Related]
4. Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas.
Hoshino M; Haraguchi Y; Hirasawa H; Sakai M; Saegusa H; Hayashi K; Horita N; Ohsawa H
Crit Care; 2001; 5(2):88-99. PubMed ID: 11299067
[TBL] [Abstract][Full Text] [Related]
5. Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin.
Katayama S; Nunomiya S; Koyama K; Wada M; Koinuma T; Goto Y; Tonai K; Shima J
Crit Care; 2017 Aug; 21(1):229. PubMed ID: 28841902
[TBL] [Abstract][Full Text] [Related]
6. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans.
Dofferhoff AS; Bom VJ; de Vries-Hospers HG; van Ingen J; vd Meer J; Hazenberg BP; Mulder PO; Weits J
Crit Care Med; 1992 Feb; 20(2):185-92. PubMed ID: 1371097
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor 2 and urokinase-type plasminogen activator in plasma and leucocytes in patients with severe sepsis.
Robbie LA; Dummer S; Booth NA; Adey GD; Bennett B
Br J Haematol; 2000 May; 109(2):342-8. PubMed ID: 10848822
[TBL] [Abstract][Full Text] [Related]
8. Compartment-specific expression of plasminogen activator inhibitor-1 correlates with severity/outcome of murine polymicrobial sepsis.
Raeven P; Feichtinger GA; Weixelbaumer KM; Atzenhofer S; Redl H; Van Griensven M; Bahrami S; Osuchowski MF
Thromb Res; 2012 May; 129(5):e238-45. PubMed ID: 22381165
[TBL] [Abstract][Full Text] [Related]
9. Coagulopathy, catecholamines, and biomarkers of endothelial damage in experimental human endotoxemia and in patients with severe sepsis: a prospective study.
Ostrowski SR; Berg RM; Windeløv NA; Meyer MA; Plovsing RR; Møller K; Johansson PI
J Crit Care; 2013 Oct; 28(5):586-96. PubMed ID: 23731819
[TBL] [Abstract][Full Text] [Related]
10. Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis.
Mesters RM; Flörke N; Ostermann H; Kienast J
Thromb Haemost; 1996 Jun; 75(6):902-7. PubMed ID: 8822584
[TBL] [Abstract][Full Text] [Related]
11. Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways.
Idell S
Crit Care Med; 2002 May; 30(5 Suppl):S274-80. PubMed ID: 12004248
[TBL] [Abstract][Full Text] [Related]
12. Fibrinolysis and coagulation in patients with infectious disease and sepsis.
Philippé J; Offner F; Declerck PJ; Leroux-Roels G; Vogelaers D; Baele G; Collen D
Thromb Haemost; 1991 Mar; 65(3):291-5. PubMed ID: 1904655
[TBL] [Abstract][Full Text] [Related]
13. The tissue factor and plasminogen activator inhibitor type-1 response in pediatric sepsis-induced multiple organ failure.
Green J; Doughty L; Kaplan SS; Sasser H; Carcillo JA
Thromb Haemost; 2002 Feb; 87(2):218-23. PubMed ID: 11858480
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor type 1 gene polymorphism and sepsis.
Hermans PW; Hazelzet JA
Clin Infect Dis; 2005 Nov; 41 Suppl 7():S453-8. PubMed ID: 16237647
[TBL] [Abstract][Full Text] [Related]
15. Time course and prognostic significance of hemostatic changes in sepsis: relation to tumor necrosis factor-alpha.
Martínez MA; Peña JM; Fernández A; Jiménez M; Juárez S; Madero R; Vázquez JJ
Crit Care Med; 1999 Jul; 27(7):1303-8. PubMed ID: 10446824
[TBL] [Abstract][Full Text] [Related]
16. Soluble Urokinase Plasminogen Activator Receptor: A New Biomarker in the Pediatric Intensive Care Unit.
El-Mekkawy MS; Saleh NY; Sonbol AA
Indian J Pediatr; 2016 Jul; 83(7):661-9. PubMed ID: 26960717
[TBL] [Abstract][Full Text] [Related]
17. Sustained high plasma plasminogen activator inhibitor-1 levels are associated with severity and mortality in septic patients.
Lorente L; Martín MM; Borreguero-León JM; Solé-Violán J; Ferreres J; Labarta L; Díaz C; Jiménez A; Páramo JA
Thromb Res; 2014 Jul; 134(1):182-6. PubMed ID: 24814968
[TBL] [Abstract][Full Text] [Related]
18. Performance of plasminogen activator inhibitor-1 as a biomarker in patients undergoing coronary angiography: Analytical and biological considerations.
Jung RG; Simard T; Di Santo P; Labinaz A; Moreland R; Duchez AC; Majeed K; Motazedian P; Rochman R; Jung Y; Hibbert B
Diab Vasc Dis Res; 2019 Sep; 16(5):478-482. PubMed ID: 31064214
[TBL] [Abstract][Full Text] [Related]
19. Significance of plasminogen activator inhibitor 2 as a prognostic marker in primary lung cancer: association of decreased plasminogen activator inhibitor 2 with lymph node metastasis.
Yoshino H; Endo Y; Watanabe Y; Sasaki T
Br J Cancer; 1998 Sep; 78(6):833-9. PubMed ID: 9743310
[TBL] [Abstract][Full Text] [Related]
20. The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis.
Brungs D; Chen J; Aghmesheh M; Vine KL; Becker TM; Carolan MG; Ranson M
Oncotarget; 2017 Apr; 8(14):23099-23109. PubMed ID: 28416743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
